Company Overview: Champions Oncology

Industry News

17 Nov

Champions Oncology Signs $2 million Contract

HACKENSACK, N.J., Nov. 17, 2016 /PRNewswire/ — Champions Oncology, Inc. (CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, announced today the signing of a $2 million contract with a large pharmaceutical customer.  This is the largest pre-clinical pharmacology...

Read more

18 Jul

Champions Oncology Successfully Delivers First AML Study

HACKENSACK, N.J., July 18, 2016 /PRNewswire/ — Champions Oncology, Inc. (CSBR), a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the successful completion of its first study in acute myeloid leukemia (AML).  Champions...

Read more

16 Jun

Champions Oncology, Inc. Announces Closing of Public Offering of Common Stock

HACKENSACK, N.J., June 15, 2016 /PRNewswire/ — Champions Oncology, Inc. (CSBR), or the “Company”, a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the closing of its previously announced underwritten public offering of 2,000,000...

Read more

10 Jun

Champions Oncology, Inc. Announces Pricing of Public Offering of Common Stock

2,000,000 Shares Priced at $2.25 Per Share HACKENSACK, N.J., June 9, 2016 /PRNewswire/ — Champions Oncology, Inc. (CSBR), or the “Company”, a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the pricing of its...

Read more

15 Mar

Champions Oncology Reports Results for the Third Quarter Ended January 31, 2016

HACKENSACK, N.J., March 15, 2016 /PRNewswire/ — Champions Oncology, Inc. (CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the third quarter ended January 31, 2016. Third Quarter and Recent Business Highlights: Delivered...

Read more

21 Jan

Champions Oncology Announces Initiation of Prospective Correlative Trial in Sarcoma

HACKENSACK, N.J., Jan. 21, 2016 /PRNewswire/ — Champions Oncology (CSBR) today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft® PDX models) in patients with metastatic or recurrent sarcoma.  Mount Sinai Hospital in Toronto, Canada is the first clinical site...

Read more

Page 1 of 212

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address